University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 20 of 24
Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas
NCT01158651
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
NCT01175382
Changes in Bone Turnover With Increased Incretin Hormone Exposure
NCT01374568
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
NCT00955903
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
NCT00919802
Home-Based Automated Therapy of Arm Function After Stroke Via Tele-Rehabilitation
NCT01157195
Longitudinal Study of Dental Implant Therapy in HIV Positive Patients
NCT01211288
Comparison of Weight Management Programs Delivered in Large Versus Small Groups
NCT02088749
Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT)
NCT00788632
Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
NCT01134731
A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide
NCT01110187
Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters
NCT01028014
Prospective Study to Evaluate Outcomes From Transoral BOT Resection for OSAHS
NCT01107795
Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators
NCT01348204
Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository
NCT01070121
Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)
NCT01113684
IVR-Enhanced Care Transition Support for Complex Patients
NCT01135381
Dietary Supplements and Aging Muscle
NCT01057082
Predictors of Response to Fenofibrate
NCT01023750
The Bone-Fat-Pancreas Axis in Children
NCT01041898
Critical Periods of Exercise
NCT01041820
Bad Genes or Genes Behaving Badly
NCT01041664
Vascular Function, Insulin Sensitivity, and Vitamin D
NCT01041547
Tissue Partitioning in Early Childhood
NCT01041794
A Reduced Carbohydrate Diet Intervention for Polycystic Ovary Syndrome (PCOS)
NCT01028989
Vitamin D, Insulin Sensitivity, and Vascular Associations in Adolescents
NCT01041365
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
NCT01005875
Voice and Swallowing Outcomes Following Revision Anterior Cervical Spine Surgery
NCT01017055
Using Virtual Reality to Train Children in Pedestrian Safety
NCT00850759
Integrated Smoking Cessation Treatment for Low Income Community Corrections
NCT01257490
Evaluation of Patients With Bulky GIST Using Sunitinib
NCT01054911
A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
NCT00964756
Chewing Gum for Weight Loss
NCT00971347
Staples Versus Suture for Cesarean Wound Closure
NCT01008449
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
NCT00853580
Chewing Gum Facilitates an Earlier Return to Bowel Function in Pediatric Scoliosis Patients: A Prospective Randomized Study
NCT02165436
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
NCT01204203
Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer
NCT00968175
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction
NCT00919347
Enhancing Physical Activity Adherence After Breast Cancer Diagnosis (BEAT Cancer II)
NCT00929617
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
NCT00856830
Clinical Trial Evaluating the Optimal Technique for Chest Tube Removal
NCT00873587
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women
NCT00869960
Improving Osteoporosis Care in High-Risk Home Health Patients
NCT00679198
Resistance Training and Physical Functioning in Head and Neck Cancer Patients
NCT01332682
TLR4 Polymorphisms and Risk of Skin Cancer
NCT03122366
The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers
NCT00862823
7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients
NCT00841035
Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding
NCT00803543
Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment
NCT01897727
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.